Feglymycin, a Novel Inhibitor of the Replication of the Human Immunodeficiency Virus. Fermentation, Isolation and Structure Elucidation.

The Journal of Antibiotics
1999.0

Abstract

The novel peptide feglymycin has been isolated from cultures of Streptomyces sp. DSM 11171 by solid phase extraction, size exclusion chromatography and repeated reversed-phase chromatography. The molecular weight was found to be 1900.90 g/mol and the molecular formula is C95H97Nl3O30. Feglymycin contains 13 amino acids of which four are 3-hydroxyphenylglycine and five are 3,5-dihydroxyphenylglycine residues. The structure of the linear peptide has been determined by 1H and 13C NMR spectroscopy. The sequence was confirmed by the observed mass spectroscopic fragmentation pattern. As well as having weak antibacterial activity, feglymycin inhibits the replication of the human immunodeficiency virus (HIV) in vitro.

Knowledge Graph

Similar Paper

Feglymycin, a Novel Inhibitor of the Replication of the Human Immunodeficiency Virus. Fermentation, Isolation and Structure Elucidation.
The Journal of Antibiotics 1999.0
Feglymycin, a Novel Inhibitor of the Replication of the Human Immunodeficiency Virus. Fermentation, Isolation and Structure Elucidation.
The Journal of Antibiotics 1999.0
Feglymycin, a unique natural bacterial antibiotic peptide, inhibits HIV entry by targeting the viral envelope protein gp120
Virology 2012.0
Biosynthesis of the Peptide Antibiotic Feglymycin by a Linear Nonribosomal Peptide Synthetase Mechanism
ChemBioChem 2015.0
Alanine Scan of the Peptide Antibiotic Feglymycin: Assessment of Amino Acid Side Chains Contributing to Antimicrobial Activity
ChemBioChem 2013.0
4862F, a New Inhibitor of HIV-1 Protease, from the Culture of Streptomyces I03A-04862
Molecules 2012.0
The Structure of Qingjingmycin A Novel Peptide-Type Metabolite of a Hybrid Strain FM3–32 Derived from<i>Streptomyces qingfengmyceticus</i>and<i>S. hydroscopicus Var. jinggangensis</i>
Natural Product Letters 1994.0
Structure of lavendomycin, a new peptide antibiotic.
Chemical and Pharmaceutical Bulletin 1985.0
Siamycins I and II, New Anti-HIV Peptides. I. Fermentation, Isolation, Biological Activity and Initial Characterization.
The Journal of Antibiotics 1995.0
EM2487, a Novel Anti-HIV-1 Antibiotic, Produced by Streptomyces sp. Mer-2487. Taxonomy, Fermentation, Biological Properties, Isolation and Structure Elucidation.
The Journal of Antibiotics 1999.0